Physician

Zulfiqar Rana, M.D.

According to 2025 Medicare claims, Zulfiqar Rana, M.D. (NPI: 1316956618) practices internal medicine in the Anniston-Oxford, AL market, with the plurality of this provider's patient population coming from Calhoun, AL. This provider's primary affiliated billing organization is ANNISTON MEDICAL CLINIC PC (NPI: 1619080017; TIN: 630704915) and primary practice location at 36207-5782. Rana is affiliated with the Aledade 79 AL MSSP Enhanced (ACO ID: A4894), participating under the MSSP model.

Rana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 712 traditional Medicare patients, billed 16,511 HCPCS/CPT codes, and received $360,095 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 14,424 prescription claims across 1,194 beneficiaries totaling $1,071,170 in drug costs, led by Ozempic (Semaglutide). DME data shows 228 claims. Open Payments data shows 14 records totaling $252. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,096	8,167	$400,301
2016	1,073	8,283	$393,586
2017	1,002	10,376	$407,366
2018	983	11,650	$402,453
2019	1,004	18,851	$454,572
2020	956	6,809	$369,065
2021	1,000	11,485	$385,049
2022	860	16,677	$355,523
2023	774	12,238	$332,115
2024	712	16,511	$360,095

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	749	15,128	$798,402
2016	777	17,484	$948,163
2017	841	18,806	$1,005,972
2018	875	19,517	$1,075,461
2019	963	21,402	$1,415,885
2020	1,034	22,297	$1,491,321
2021	1,201	17,712	$1,208,738
2022	1,184	16,588	$1,163,611
2023	1,117	14,652	$1,209,049
2024	1,194	14,424	$1,071,170

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	213	871	$39,622
2016	350	1,197	$55,486
2017	309	1,218	$53,031
2018	254	1,238	$65,540
2019	218	1,313	$62,860
2020	153	972	$54,767
2021	96	713	$48,207
2022	58	462	$31,786
2023	37	384	$26,286
2024	22	228	$22,689

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	471	471	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	572	1,577	$82
99443	Telephone medical discussion with physician, 21-30 minutes	279	443	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	230	336	$52
G0444	Annual depression screening, 5 to 15 minutes	465	468	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	166	5,636	$176,035
Eliquis	Apixaban	100	5,031	$95,832
Jardiance	Empagliflozin	70	3,930	$76,644
Trulicity	Dulaglutide	46	1,466	$50,027
Xarelto	Rivaroxaban	43	2,070	$37,183

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	38	$12,513
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	57	$4,492
K0823	Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds	Y	N/R	26	$3,613
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	22	46	$769
E0630	Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)	Y	N/R	13	$643

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$252	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Zulfiqar Rana, M.D.?

Tedicare shows public-source Medicare data for Zulfiqar Rana, M.D. (NPI 1316956618), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zulfiqar Rana, M.D. have ACO affiliation data?

Zulfiqar Rana, M.D. is shown with ACO affiliation data for Aledade 79 AL MSSP Enhanced (MSSP, ACO ID A4894).

What billing organization is linked to Zulfiqar Rana, M.D.?

Zulfiqar Rana, M.D. is linked to ANNISTON MEDICAL CLINIC PC (billing NPI 1619080017) in the available physician profile data.

Does Zulfiqar Rana, M.D. have Open Payments data?

Zulfiqar Rana, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.